Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,660.00    2.00 (0.12%)
Bid:
1,664.00
Ask:
1,666.00
Spread: 2.00 (0.12%)
Market Cap: £488.90m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Interim Management Statement

8 Aug 2012 07:00

RNS Number : 5235J
Avon Rubber PLC
08 August 2012
Β 

ο»Ώ

Strictly embargoed until 07:00 Wednesday 8 August 2012

AVON RUBBER p.l.c. ("Avon", the "Group" or the "Company")

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD FROM 1 APRIL 2012 TO 7 AUGUST 2012

Protection & Defence

In Protection & Defencethe full yearorder intake for the Division is expected to be 38% up on the previous year and with a significant element of this for delivery in future years, we have improved visibility of revenues from both the DoD and commercial customers for 2013.

Β 

Orders in hand from the US Department of Defense (DoD) will allow us to deliver similar volumes of the M50 respirator in the second half of our 2012 financial year to the first half of the year. As expected we have seen an acceleration in the delivery of spare filters to the DoD since the half year, albeit the overall level of filter orders will be below that of the previous year. We expect filter demand to grow as more mask systems are delivered although customer scheduling of filter deliveries remains difficult to predict.

Β 

Project Fusion, our new program to expand and enhance our product range, remains on track to provide further organic growth from 2013/4.

Β 

Dairy

In Dairy we have seen further growth in sales of our Milk-Rite brand, in particular the Impulse Mouthpiece Vented Liner. Our sales and distribution centre in China is progressing well, in line with expectations.

Β 

Net debt

The Group's balance sheet remains robust. Net debt at 30 June 2012 was Β£10.2m (30 September 2011: Β£11.8m) reflecting the timing of working capital movements and the significant investment made in product development during the year.Β 

Β 

Outlook

The business as a whole has progressed further in this period with continued investment in product development and our brands and distribution channels. With improved operational performance from Protection & Defence and the Dairy business performing strongly, we continue to expect that the results for the second half of the year will be stronger than the first half with year on year growth comparable with the level seen during the first half.

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896870

Sarah Matthews-DeMers, Group Financial Controller

01225 896835

Miles Ingrey-Counter, Company Secretary

01225 896850

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

Β 

Β 

Β 

Β 

Β 

Β Β 

Β 

Β 

Β 

Β 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological,Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder,

emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced

CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised

solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and

tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSSSAFMWFESEDA
Date   Source Headline
3rd Dec 20088:40 amRNSDirector/PDMR Shareholding
1st Dec 20084:09 pmRNSDirector/PDMR Shareholding
28th Nov 200810:28 amRNSDirector/PDMR Shareholding
27th Nov 20086:05 pmRNSDirector/PDMR Shareholding
27th Nov 20085:50 pmRNSDirector/PDMR Shareholding
27th Nov 20085:40 pmRNSDirector/PDMR Shareholding
27th Nov 20085:35 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSFinal Results
19th Nov 200812:00 pmRNSNotice of Results
10th Nov 200812:15 pmRNSSale of UK Mixing Facility
23rd Oct 20089:34 amRNSReplacement for Period End Update
23rd Oct 20087:00 amRNSPeriod End Update
28th Aug 20087:00 amRNSContract Win
13th Aug 20083:21 pmRNSBlocklisting Interim Review
8th Aug 20087:00 amRNSInterim Management Statement
17th Jul 20089:33 amRNSDirector/PDMR Shareholding
30th Jun 200811:08 amRNSDirector/PDMR Shareholding
23rd Jun 20089:11 amRNSBoard and Senior Management A
2nd Jun 20082:11 pmRNSDirector/PDMR Shareholding
28th May 20087:00 amRNSInterim Results
19th May 20089:00 amRNSNotice of Results
19th May 20087:00 amRNSContract Award
2nd May 20082:45 pmRNSDirector/PDMR Shareholding
21st Apr 20087:00 amRNSTrading Update
4th Mar 20082:15 pmRNSCompletion of Disposal
18th Feb 20083:47 pmRNSDirector/PDMR Shareholding
8th Feb 20082:38 pmRNSDirector/PDMR Shareholding
8th Feb 20087:00 amRNSDisposal
29th Jan 20082:08 pmRNSDirector/PDMR Shareholding
24th Jan 20084:53 pmRNSAnnual Information Update
24th Jan 20083:07 pmRNSResult of AGM
24th Jan 20082:41 pmRNSDirector/PDMR Shareholding
23rd Jan 200810:30 amRNSAGM Statement
14th Jan 20083:41 pmRNSHolding(s) in Company
11th Jan 20082:12 pmRNSDirector/PDMR Shareholding
9th Jan 20085:05 pmRNSHolding(s) in Company
7th Jan 20082:51 pmRNSTotal Voting Rights
3rd Jan 20083:50 pmRNSHolding(s) in Company
20th Dec 20072:48 pmRNSDirector/PDMR Shareholding
20th Dec 200712:00 pmRNSAnnual Report & Accounts
4th Dec 200712:19 pmRNSTotal Voting Rights
29th Nov 20077:01 amRNSFinal Results
16th Nov 200712:09 pmRNSBlocklisting Interim Review
13th Nov 200712:30 pmRNSTotal Voting Rights
30th Oct 20077:01 amRNSNotice of Results
17th Oct 20073:27 pmRNSHolding(s) in Company
17th Oct 20077:00 amRNSViking Z Seven Approval
8th Oct 20071:33 pmRNSUK Mixing Operation
5th Oct 20077:00 amRNSRe: US JSGPM program
1st Oct 20075:31 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.